Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-06 Purchase | 2021-12-06 4:16 pm | NEOGENOMICS INC | NEO | Mallon Mark Chief Executive Officer | 17,000 | $30.63 | $520,710 | 223,752 (Direct) | View |
| 2021-02-26 Sale | 2021-03-02 4:37 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Mallon Mark Chief Executive Officer | 30,675 | $9.11 | $279,449 | 470,605 (Direct) | View |
| 2020-05-11 Sale | 2020-05-13 5:21 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Mallon Mark Chief Executive Officer | 23,206 | $10.35 | $240,182 | 501,280 (Direct) | View |
| 2020-02-21 Sale | 2020-02-25 4:45 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Mallon Mark Chief Executive Officer | 7,984 | $11.63 | $92,854 | 303,425 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-01 Option Award | 2022-03-03 7:59 pm | N/A 2029-03-01 | NEOGENOMICS INC | NEO | Mallon Mark Chief Executive Officer | 490,234 | $0 | 866,844 (Direct) | View |
| 2021-12-30 Option Award | 2021-12-30 6:05 pm | N/A N/A | NEOGENOMICS INC | NEO | Mallon Mark Chief Executive Officer | 152,858 | $0 | 376,610 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-21 6:19 pm | N/A 2028-04-19 | NEOGENOMICS INC | NEO | Mallon Mark Chief Executive Officer | 206,752 | $0 | 206,752 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 4:29 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Mallon Mark Chief Executive Officer | 221,061 | $0 | 524,486 (Direct) | View |